# Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects

> **NCT05976737** · PHASE1 · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 68 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Test (T) Entacapone,Levodopa and Carbidopa Tablets (II)
- **DRUG:** Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II)

## Key facts

- **NCT ID:** NCT05976737
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-17
- **Primary completion:** 2023-09-07
- **Final completion:** 2024-07-12
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05976737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05976737, "Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05976737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*